These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36540019)
1. The role of surveillance imaging for resected high-risk melanoma. Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma. Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966 [TBL] [Abstract][Full Text] [Related]
3. Yield of baseline imaging for distant metastases in high-risk primary melanoma. Yan MK; Adler NR; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ J Surg Oncol; 2022 Jun; 125(8):1312-1317. PubMed ID: 35262187 [TBL] [Abstract][Full Text] [Related]
4. Surveillance strategies in the follow-up of melanoma patients: too much or not enough? Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057 [TBL] [Abstract][Full Text] [Related]
6. PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study. Madu MF; Timmerman P; Wouters MWJM; van der Hiel B; van der Hage JA; van Akkooi ACJ Melanoma Res; 2017 Jun; 27(3):251-257. PubMed ID: 28225434 [TBL] [Abstract][Full Text] [Related]
7. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance. Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702 [TBL] [Abstract][Full Text] [Related]
8. Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence. Ibrahim AM; Le May M; Bossé D; Marginean H; Song X; Nessim C; Ong M Ann Surg Oncol; 2020 Oct; 27(10):3683-3691. PubMed ID: 32363515 [TBL] [Abstract][Full Text] [Related]
9. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma. Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712 [TBL] [Abstract][Full Text] [Related]
10. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma. Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039 [TBL] [Abstract][Full Text] [Related]
11. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients. Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809 [TBL] [Abstract][Full Text] [Related]
12. Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients. Helvind NM; Weitemeyer MB; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR Ann Surg Oncol; 2023 Apr; 30(4):2377-2388. PubMed ID: 36752970 [TBL] [Abstract][Full Text] [Related]
13. Utility of PET/CT in patients with stage I-III melanoma. Avilés Izquierdo JA; Molina López I; Sobrini Morillo P; Márquez Rodas I; Mercader Cidoncha E Clin Transl Oncol; 2020 Aug; 22(8):1414-1417. PubMed ID: 31873917 [TBL] [Abstract][Full Text] [Related]
14. The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma. Ravichandran S; Nath N; Jones DC; Li G; Suresh V; Brys AK; Hanks BA; Beasley GM; Salama AKS; Howard BA; Mosca PJ Surg Oncol; 2020 Dec; 35():533-539. PubMed ID: 33161362 [TBL] [Abstract][Full Text] [Related]
15. Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy. Bloemendal M; van Willigen WW; Bol KF; Boers-Sonderen MJ; Bonenkamp JJ; Werner JEM; Aarntzen EHJG; Koornstra RHT; de Groot JWB; de Vries IJM; van der Hoeven JJM; Gerritsen WR; de Wilt JHW Ann Surg Oncol; 2019 Nov; 26(12):3945-3952. PubMed ID: 30830540 [TBL] [Abstract][Full Text] [Related]
16. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma? England P; Hong Z; Rhea L; Hirbe A; McDonald D; Cipriano C Clin Orthop Relat Res; 2020 Dec; 478(12):2812-2820. PubMed ID: 32667755 [TBL] [Abstract][Full Text] [Related]
17. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064 [TBL] [Abstract][Full Text] [Related]
18. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma. Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829 [TBL] [Abstract][Full Text] [Related]
19. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence. Abbott RA; Acland KM; Harries M; O'Doherty M Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913 [TBL] [Abstract][Full Text] [Related]